Saamyabiotech

Hyderabad, India Founded: 2002 • Age: 24 yrs Listed
News on games is delivered through a dedicated blog site.

About Saamyabiotech

Saamyabiotech is a publicly listed company based in Hyderabad (India) founded in 2002. News on games is delivered through a dedicated blog site. Its Indian entity Saamya Biotech (India) Limited reported revenue of β‚Ή14.51 Cr. Its focus areas include Biopharma Outsourcing and Diversified.

Company details

Saamyabiotech was established in 2002 in Hyderabad, India. A blog site centered on games news is operated, where updates, articles, and insights into the gaming sector are published. Content is hosted on saamyabiotechltd.com, targeting readers interested in industry developments. Digital media operations are conducted from the companys base in India, focusing on informational services without additional commercial offerings.

  • Headquarters Hyderabad, India
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website saamyabiotechltd.com
  • Legal Name Saamya Biotech (India) Limited
  • Date of Incorporation 13 Aug, 2002
  • Jurisdiction Andhra Peadesh, Andhra Pradesh, India
Key Metrics
  • Annual Revenue
    ₹14.51 Cr

    FY 2016 · -50% YoY

  • Net Loss
    -₹44.1 Lakh

    FY 2016 · -3% margin

  • EBITDA
    -₹1.8 Lakh

    FY 2016 · 0% margin

Board of directors of Saamya Biotech (India) Limited (Saamyabiotech)

Saamya Biotech (India) Limited is the primary company behind Saamyabiotech. The board of Saamya Biotech (India) Limited currently have 5 directors; the longest-serving is Yala Sonia Reddy, appointed in 2002. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Yala Sonia Reddy
DIN 00166243
Whole-time director13 Aug 200224 yrs 2 moSaamya Biotech (India) Limited
Podduturi Naveen Chandar Reddy
DIN 02203603
Director27 Dec 200718 yrs 9 moSaamya Biotech (India) Limited
Pannala Reddy Suresh
DIN 02242819
Director18 Jul 200818 yrs 3 moSaamya Biotech (India) Limited
Manivardhan Reddy Yala
DIN 01368438
Managing Director05 Sep 201511 yrs 1 moSaamya Biotech (India) Limited
Santosh Jagannath Sawant
DIN 05153202
Director13 Nov 201510 yrs 11 moSaamya Biotech (India) Limited

Financials of Saamyabiotech

Figures of Saamya Biotech (India) Limited, the primary company behind Saamyabiotech, for FY 2016. Revenue was ₹14.51 Cr (-50% year on year). Net loss was -₹44.1 Lakh (-3% margin). EBITDA was -₹1.8 Lakh (0% margin).

  • ₹14.51 CrRevenue · FY 2016 · -50% YoY
  • -₹44.1 LakhNet loss · -3% margin
  • -₹1.8 LakhEBITDA · 0% margin
  • ₹24.88 CrPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Saamya Biotech (India) Limited are on its company page.

Premium access

Detailed financial statements for Saamyabiotech

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Saamyabiotech (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Saamyabiotech

Saamya Biotech's board meeting on March 09, 2017
Moneycontrol β€’ 9 years ago
Saamya Biotech: Outcome of board meeting
Moneycontrol β€’ 9 years ago
Premium access

Complete news archive for Saamyabiotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saamyabiotech

Saamyabiotech was founded in 2002.

Saamyabiotech is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

The primary company behind Saamyabiotech, Saamya Biotech (India) Limited, reported revenue of β‚Ή14.51 Cr for FY 2016, down 50% year on year.

Saamyabiotech was established in 2002 in Hyderabad, India. A blog site centered on games news is operated, where updates, articles, and insights into the gaming sector are published. Content is hosted on saamyabiotechltd.com, targeting readers interested in industry developments. Digital media operations are conducted from the companys base in India, focusing on informational services without additional commercial offerings.

Saamyabiotech operates through Saamya Biotech (India) Limited.

The legal entities of Saamyabiotech currently have 5 directors, including Manivardhan Reddy Yala, Pannala Reddy Suresh, Santosh Jagannath Sawant and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available